---
layout: post
title: "特一药业2021年度净利润预增174%-242%"
date: 2022-01-12 17:13:04 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002728" data-code="002728|0|2" data-code2="002728|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002728&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002728_0" data-code="K 002728|0|2" data-code2="K 002728|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>特一药业披露业绩预告。公司预计2021年盈利12,000.00万元-15,000.00万元，比上年同期增长173.87%-242.34%。报告期内，公司业务基本恢复至正常水平，销售收入特别是核心产品“特一”牌止咳宝片的销售恢复较好。<br /></p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201122245393458>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)